Cumberland Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for CUMBERLAND PHARMS, and what generic alternatives to CUMBERLAND PHARMS drugs are available?
CUMBERLAND PHARMS has six approved drugs.
There are seventeen US patents protecting CUMBERLAND PHARMS drugs.
There are one hundred and eighty-four patent family members on CUMBERLAND PHARMS drugs in thirty-nine countries and fifteen supplementary protection certificates in fourteen countries.
Summary for Cumberland Pharms
International Patents: | 184 |
US Patents: | 17 |
Tradenames: | 7 |
Ingredients: | 6 |
NDAs: | 6 |
Drugs and US Patents for Cumberland Pharms
Expired US Patents for Cumberland Pharms
Paragraph IV (Patent) Challenges for CUMBERLAND PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 200 mg/mL, 30 mL vials | ➤ Subscribe | 2012-04-04 |
International Patents for Cumberland Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20120138229 | See Plans and Pricing |
Slovenia | 1276759 | See Plans and Pricing |
Canada | 2766367 | See Plans and Pricing |
Malaysia | 173215 | See Plans and Pricing |
Australia | 5746401 | See Plans and Pricing |
Japan | 2004501161 | See Plans and Pricing |
Norway | 2011025 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cumberland Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1292612 | PA2012002,C1292612 | Lithuania | See Plans and Pricing | PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902 |
1292612 | 132012902025885 | Italy | See Plans and Pricing | PRODUCT NAME: TELAVANCINA(VIBATIV); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/11/705/001-002, 20110902 |
1292612 | 2011C/045 | Belgium | See Plans and Pricing | PRODUCT NAME: VIBATIV - TELAVANCINE; AUTHORISATION NUMBER AND DATE: EU/1/11/705-001 20110902 |
1292612 | PA2012002 | Lithuania | See Plans and Pricing | PRODUCT NAME: TELAVANCINUM; REGISTRATION NO/DATE: EU/1/11/705/001, 2011 09 02 EU/1/11/705/002 20110902 |
1292612 | 122011100062 | Germany | See Plans and Pricing | PRODUCT NAME: TELAVANCIN ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ HIERVON, EINSCHLIESSLICH TELAVANCINHYDROCHLORID; REGISTRATION NO/DATE: EU/1/11/705/001-002 20110902 |
1292612 | 91908 | Luxembourg | See Plans and Pricing | 91908, EXPIRES: 20260501 |
1292612 | C300507 | Netherlands | See Plans and Pricing | PRODUCT NAME: TELAVANCINE, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, INCLUSIEF TELAVANCINE HYDROCLORIDE; REGISTRATION NO/DATE: EU/1/11/705/001 - 002 20110902 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.